Biological drug leaders meet

Home > Business > Industry

Biological drug leaders meet

Published: 27 Jun. 2016, 21:19

From left, Tom Pike, CEO of Quintiles, a biopharmaceutical contract research organization; Julie Gerberding, executive vice president of MSD and former director of the U.S. Centers for Disease Control; Brian H. Gu, co-head of JP Morgan Chase & Co.’s Asia Pacific M&A, TMT and Healthcare; and Sohn Yeo-won, National Institute of Food and Drug Safety Evaluation.

The group held a press conference Monday at the Global Bio Conference at Seoul’s COEX exhibition center in southern Seoul. About 2,000 officials from the biopharmaceutical industry, including Celltrion CEO Kim Hyoung-ki, as well as scholars and government officials are attending the forum that ends Friday. [NEWSIS]